Primary study · included by 2 reviews

Genetic polymorphism of drug metabolizing enzymes (GSTM1 and CYP1A1) as risk factors for oral premalignant lesions and oral cancer.

Shukla et al. 2012 · Shukla Deepika, Dinesh Kale Alka, Hallikerimath Seema, et al. · Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia · 2012

Included by

Assessment of genetic susceptibility in patients with oral squamous cell carcinoma: a systematic review and meta-analysis.

Non-Cochrane · aetiology · 2026 · cited as Shukla 2012 · Reference list (included study cited as ref 70)

The review does not say which of its outcomes this study informs.

Systematic evaluation of genetic polymorphisms in carcinogen metabolizing enzymes associated with oral potentially malignant disorders progression to oral cancer risk.

Non-Cochrane · aetiology · 2026 · cited as Shukla et al. 2012 · Supplementary Table S2; references 7–18

The review does not say which of its outcomes this study informs.

2 including reviews in total.